Delivery Order #SPE2D826FDV56

Delivery Order for Mydayis Capsules via AmerisourceBergen under NPV Prime Vendor IDIQ

This contract award represents a definitive delivery order issued under an existing indefinite delivery indefinite quantity (IDIQ) contract vehicle known as the NPV Pharm Prime Vendor agreement. The recipient, AmerisourceBergen Drug Corporation, is a leading pharmaceutical sourcing and distribution company. The order specifically procures Mydayis 12.5mg capsules, a prescription pharmaceutical product. The significance of this award lies in its support for federal healthcare initiatives by ensuring timely access to essential drug therapies through a well-established supply chain partner. The scope covers the precise delivery of the specified medication within a short performance window at the Conshohocken, Pennsylvania location. This award was a task order under a competitively awarded IDIQ contract originally established in late 2022 with a multi-year validity. The short-term nature of the delivery aligns with ongoing procurement strategies to maintain consistent pharmaceuticals availability. The parent contract's long duration and broad scope underline the strategic partnership between the government and AmerisourceBergen, facilitating responsive and reliable pharmaceutical supply services.

Description

4571114267!MYDAYIS CAPS 12.5MG

View original record